Queen Mary University of London: Whole Genome Sequencing Improves Diagnosis of Rare Diseases and Shortens Diagnostic Journeys for Patients
November 11, 2021
November 11, 2021
LONDON, England, Nov. 11 (TNSJou) -- Queen Mary University of London issued the following news:
A world-first scientific study, published today in the New England Journal of Medicine, has shown that whole genome sequencing (WGS) can uncover new diagnoses for people across the broadest range of rare diseases investigated to date and could deliver enormous benefits across the NHS.
The pilot study of rare undiagnosed diseases involved analysing the genes of 4,660 people fr . . .
A world-first scientific study, published today in the New England Journal of Medicine, has shown that whole genome sequencing (WGS) can uncover new diagnoses for people across the broadest range of rare diseases investigated to date and could deliver enormous benefits across the NHS.
The pilot study of rare undiagnosed diseases involved analysing the genes of 4,660 people fr . . .